Kunming Pharmaceuticals, Inc.
Kunming Pharmaceuticals, Inc.
Explore linked clinical trials.4 results · Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Multicentre, Randomised, Double-blind, Positive-control Clinical Trial Evaluating Dihydroartemisinin Tablets for the Treatment of Discoid Lupus Erythematosus | Skin and Connective Tissue Diseases, connective tissue disorder, cutaneous lupus erythematosus, discoid lupus erythematosus, skin disorder | Not yet recruiting | Phase 2 | 2026-04-30 | NCT07557927 | |
| A Phase I Clinical Study to Evaluate the Safety, Tolerability, and Pharmacokinetic Profile of Gastrodin Injection in Healthy Chinese Subjects | Confusion, Neurobehavioral Manifestations, Neurologic Manifestations, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, cognitive disorder, delirium, nervous system disorder, psychiatric disorder | Not yet recruiting | Phase 1 | 2026-02-19 | NCT07422142 | |
| Efficacy and Safety of the KPCXM18 Injection in Patients With Acute Ischemic Stroke | Acute Ischemic Stroke, brain disorder, cardiovascular disorder, central nervous system disorder, cerebrovascular disorder, ischemic stroke, nervous system disorder, stroke disorder, vascular disorder | Recruiting | Phase 2 | 2025-12-12 | NCT07279493 | |
| A Trial to Evaluate KPC000154 Tablets in Healthy Subjects | Healthy Subjects、Lipid Metabolism | Not yet recruiting | Phase 1 | 2025-03-10 | NCT06867406 |